361 related articles for article (PubMed ID: 26148230)
21. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22).
Panagopoulos I; Aman P; Fioretos T; Höglund M; Johansson B; Mandahl N; Heim S; Behrendtz M; Mitelman F
Genes Chromosomes Cancer; 1994 Dec; 11(4):256-62. PubMed ID: 7533529
[TBL] [Abstract][Full Text] [Related]
22. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation.
Benoit G; Altucci L; Flexor M; Ruchaud S; Lillehaug J; Raffelsberger W; Gronemeyer H; Lanotte M
EMBO J; 1999 Dec; 18(24):7011-8. PubMed ID: 10601023
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
[TBL] [Abstract][Full Text] [Related]
24. The oncogenic TLS-ERG fusion protein exerts different effects in hematopoietic cells and fibroblasts.
Zou J; Ichikawa H; Blackburn ML; Hu HM; Zielinska-Kwiatkowska A; Mei Q; Roth GJ; Chansky HA; Yang L
Mol Cell Biol; 2005 Jul; 25(14):6235-46. PubMed ID: 15988032
[TBL] [Abstract][Full Text] [Related]
25. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
[TBL] [Abstract][Full Text] [Related]
26. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
Mochmann LH; Bock J; Ortiz-Tánchez J; Schlee C; Bohne A; Neumann K; Hofmann WK; Thiel E; Baldus CD
Oncogene; 2011 Apr; 30(17):2044-56. PubMed ID: 21242973
[TBL] [Abstract][Full Text] [Related]
28. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
[TBL] [Abstract][Full Text] [Related]
29. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease.
Kanazawa T; Ogawa C; Taketani T; Taki T; Hayashi Y; Morikawa A
Leuk Lymphoma; 2005 Dec; 46(12):1833-5. PubMed ID: 16263589
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
31. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.
Fazi F; Zardo G; Gelmetti V; Travaglini L; Ciolfi A; Di Croce L; Rosa A; Bozzoni I; Grignani F; Lo-Coco F; Pelicci PG; Nervi C
Blood; 2007 May; 109(10):4432-40. PubMed ID: 17244680
[TBL] [Abstract][Full Text] [Related]
32. Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia.
Panagopoulos I; Gorunova L; Zeller B; Tierens A; Heim S
Oncol Rep; 2013 Dec; 30(6):2587-92. PubMed ID: 24068373
[TBL] [Abstract][Full Text] [Related]
33. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
34. TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells.
Pan J; Zou J; Wu DY; Roberson RS; Hennings LJ; Ma X; Yared M; Blackburn ML; Chansky HA; Yang L
Mol Cancer Res; 2008 May; 6(5):862-72. PubMed ID: 18505930
[TBL] [Abstract][Full Text] [Related]
35. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
36. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation.
Ichikawa H; Shimizu K; Hayashi Y; Ohki M
Cancer Res; 1994 Jun; 54(11):2865-8. PubMed ID: 8187069
[TBL] [Abstract][Full Text] [Related]
37. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
Panagopoulos I; Mandahl N; Mitelman F; Aman P
Oncogene; 1995 Sep; 11(6):1133-7. PubMed ID: 7566973
[TBL] [Abstract][Full Text] [Related]
38. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
39. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
40. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
